The remaining 365 (88%) new chemicals have been under EPA review for more than 90 days. a 7% increase since May 17 — resulting in a backlog of advanced chemistries ensnared in the EPA’s review pipeline.
365-Day Backlog
While 243 (59%) of PMN cases are under review for greater than or equal to 365 days, 67% of the new chemicals backlog remained under review for greater than or equal to 365 days. Since May 17, the 365-day backlog declined 15%.
Delays in TSCA New Chemical Reviews and U.S. Manufacturing
EPA's inability to meet the mandated 90-day deadline for conducting new chemical reviews has led to a significant backlog in the TSCA New Chemicals Program. This persistent backlog poses a serious threat to American innovation, manufacturing, and global competitiveness. In a 2022 survey, ACC member companies representing nearly one-fifth of U.S. chemical industry sales reported systemic delays, disregarded company-submitted data, and inconsistent chemical reviews:
- 81% reported EPA taking more than 365 days for their new chemical reviews to be completed.
- 70% of respondents reported that they have decided to introduce new chemicals outside of the U.S. due to uncertainties and challenges with the EPA’s New Chemicals Program.
- 70% reported their new chemical reviews being negatively impacted by EPA’s policy change to disregard workplace requirements and protocols to use personal protective equipment (PPE).
- 66% reported their biggest problem to be EPA delays in new chemical reviews and the resulting inability to start manufacturing in the U.S.
Read ACC’s backgrounder on EPA’s TSCA New Chemicals Program